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Background: The involvement of VSX1 gene for the genetic basis of keratoconus is unclear and controversial. The
genetic screening of VSX1 from different ethnic populations can enlighten this subject. The aim of the present
study is to investigate the role of VSX1 gene in patients with sporadic cases of keratoconus from South India.
Methods: The VSX1 gene coding regions, including exon-intron boundaries were screened by direct sequencing
analysis in 117 sporadic cases of keratoconus. The identified variations were also analyzed in 108 ethnic matched
healthy blood donors.
Results: In the VSX1 gene screening, no pathogenic mutation was identified, whereas we could find the presence
of four reported single nucleotide polymorphisms; c.546A>G (rs12480307), c.627+23G>A (rs6138482), c.627+84T>A
(rs56157240) and c.504-24C>T (IVS3-24C). These variations were observed in similar frequency between cases and
controls.
Conclusions: The lack of VSX1 pathogenic variations in a large number of unrelated sporadic keratoconus patients
tend to omit its role, and corroborate the involvement of other genetic, environmental or behavioural factors in the
development of this complex disorder.
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Keratoconus (KTCN; [OMIM] 148300) is a corneal
ectatic disorder characterized by progressive thinning of
the central cornea, which acquires a conical shape ra-
ther than its normal dome-shaped curve. This results in
optical aberrations leading to distorted blurred vision,
progressive high myopia and irregular astigmatism [1].
Keratoconus is mostly bilateral but can be unilateral,
onset in teenage years and often progresses until the
third or fourth decade of life [2]. The prevalence of
keratoconus is estimated to be 1 in 2000 in the general
population [2,3]. It is more common in patients with
atopic conditions, such as asthma, dermatitis, and
found to be associated with many other genetic disor-
ders like Down syndrome, posterior polymorphous cor-
neal dystrophy, Leber congenital amaurosis, retinitis* Correspondence: sundar@aravind.org
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reproduction in any medium, provided the orpigmentosa, Marfan syndrome, mitral valve prolapse and
other documented associations [1,2,4]. It occurs usually
in a sporadic form, though positive familial history has
been reported in 6-10% of patients, with mostly auto-
somal dominant and sometime recessive or X-linked
mode of inheritance [4-6]. Common histopathological
features of KTCN include stromal thinning, iron depo-
sition in the epithelial basement membrane, breaks in cor-
neal Bowman’s layer and sometimes endothelial damage
[2,7]. The disease generally occurs with no gender prepon-
derance; however, few evidence suggests a higher preva-
lence in either male or female [1,6,8]. At present, the
milder forms of keratoconus are corrected by spectacles
or contact lenses. In 10% to 20% of KTCN cases, cor-
neal thinning may reach such a severity that it be-
comes very essential to undergo corneal transplantation
or penetrating keratoplasty, which has emerged as a
major medical burden in many countries [2,9]. The
exact etiology of KTCN is still unknown, and its patho-
genesis may involve genetic as well as environmental orLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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atopy/allergy, contact lens wear and mechanical eye
rubbing, etc. [10-12]. Primarily, the genetic factors may
play an important role in the development of
keratoconus as evidenced by studies of familial inherit-
ance, concordance between monozygotic twins and as-
sociation with other known genetic disorders [12-14].
By linkage analysis and association studies, various loci
have been mapped in families from different ethnic pop-
ulations, well summarized by Nowak DM et al. [12].
Based on associated loci, genes such as SPARC, LOX,
TIMP3, COL6A1, COL8A1, MMP9, and MMP2, etc.,
have been examined for their involvement [12,15]. The
SOD1 and CRB1 were also analyzed as possible candi-
date genes because of their role in keratoconus associ-
ated disease like Down syndrome and Leber congenital
amaurosis respectively [16,17]. However, genes under
such studies, have not provided enough evidence for be-
ing an appropriate candidate gene in the pathogenesis
of KTCN. One of the well-studied genes in genetic asso-
ciation with keratoconus is VSX1. Human VSX1
[OMIM 605020] is a member of the VSX1 group of ver-
tebrate paired-like homeodomain transcription factors
localized to human chromosome 20p11-q11. Heon
et al., [18] first identified VSX1 mutations in patients
with either keratoconus or posterior polymorphous
corneal dystrophy (PPCD). This led to the assumption
that mutations in the VSX1 gene may be involved in
pathogenesis of keratoconus. A number of other stud-
ies, further showed the presence of VSX1 variants in
keratoconus patients from different ethnic populations
[19-24]. Among them, several variants were found in
highly conserved residues of VSX1, and predicted to
be pathogenic by the bioinformatics tools like
PolyPhen, SIFT, etc. [21,23]. The exonic and intragenic
polymorphisms were frequently reported in such studies,
and found to be associated with the disease in a few cases
[22,25]. On the other hand, many other studies excluded
those previously reported VSX1 variations to be pathogenic,
and showed a lack of mutation or association [26-30].
Therefore, the role of VSX1 in KTCN pathogenesis is am-
biguous, and further genetic studies are required for any
persuasive conclusions. In this study, we have undertaken
the sequence analysis of coding regions of VSX1 gene in
order to determine its genetic involvement in South Indian
patients with sporadic form of keratoconus.
Methods
Clinical assessment
Patients affected with keratoconus were recruited from
cornea clinic, Aravind eye hospital, Madurai, between
the period of 2009 to 2011. The study consisted of 117
unrelated sporadic keratoconus patients, including 69
males and 48 females with an age range between 12 to46 years old and mean age 23.1 years (SD ±6.1 years). A
total of 108 ethnic-matched healthy blood donors with
age range between 17 to 65 years old and mean age 24.6
years (SD ±9.4), including 27 males and 81 females, with
no major ocular disorders were taken as controls. Any
KTCN subjects with co-existing allergy/atopy, or sys-
temic diseases/syndromes such as Down syndrome,
Leber congenital amaurosis, Ehlers-Danlos syndrome,
osteogenesis imperfecta and pellucid marginal degener-
ation, or post-LASIK or other refractive surgeries were
excluded from this study. All study subjects belonged to
South Indian ethnicity, mainly from the region of Tamil
Nadu. Informed consent was obtained from each of the
subjects. The study obeyed the tenets of the declaration
of Helsinki and was approved by the institutional review
board of Aravind eye hospital, Madurai, Tamil Nadu,
India. The diagnosis of KTCN was based on the presence
of important clinical features such as Munson’s sign,
Vogt’s striae, Fleischer ring, prominent corneal nerves,
corneal scarring, etc. The orbscan II parameters, (anter-
ior float, posterior float, keratometry and pachymetry
reading) operated with software version 3.12 (Bausch &
Lomb Inc., Rochester, NY) were taken for the final
diagnosis using following measurements (a) ratio be-
tween the radius of anterior best-fit sphere (BFS) and
posterior BFS >1.27 (b) power of posterior BFS >55D
(c) difference between highest and lowest posterior float
points >100 μ (d) corneal thickness index (CTI) >1.16
(e) irregularity at 3 mm zone >1.5D; 5 mm zone >2.5D
and (f ) K reading >47D. The patients diagnosed with
forme-frusta keratoconus were not included in the
study. Intra ocular pressure using pulsair non-contact
tonometry was also taken for all patients. The study in-
volved only sporadic keratoconus cases, and patients
with a family history of KTCN were excluded. Further-
more, to confirm the sporadic nature of cases, three to
four immediate available family members of each pa-
tient were clinically examined.
DNA extraction and PCR amplification
Genomic DNA was isolated from peripheral blood leu-
kocytes using the salt precipitation method as described
by Miller et al., [31]. The primer pairs used to amplify
each of the five coding VSX1 exons were previously de-
scribed [19]. PCR reaction (Eppendorf mastercycler,
Westbury, NY) was carried out in a 20 μl reaction mix-
ture set up containing 2 μl of 10X PCR buffer with 1.5
mM MgCl2, 200 mM dNTP, 0.2 mM of each forward
and reverse primer, 0.2 U Taq DNA polymerase (Sigma)
and 50 ng genomic DNA. The genomic DNA underwent
initial denaturation for 5 min at 95°C, followed by 35
cycles at 94°C for 1 min, respective exons annealing at
58°C (ex1), 59°C (ex2), 62°C (ex3,4,5) for 1 min, exten-
sion at 72°C for 30 sec and final extension for 5 min at
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intron junctions were examined by bidirectional sequen-
cing analysis.
DNA sequencing
The PCR products were pooled and purified using the
gel-elution kit method (Bio Basic Inc. Canada). The puri-
fied PCR products were sequenced bidirectionally using
Big Dye Terminator ready reaction mix and analyzed on
an ABI-3130 genetic analyzer (Applied Biosystems,
Fostercity, CA). The sequence data analysis was done
using BLAST software and compared with the published
nucleotide sequence of the VSX1 gene [Gen Bank acces-
sion number NM_014588]. The identified variations were
evaluated using Alamut software version 2.1e (Interactive
Biosoftware, Rouen, France). The nomenclature, location
and classification of variations were done based on the
Alamut output.
Comparative analysis
A comparative statistical analysis of genotype and allele
frequency was done using chi-square or Fisher’s exact
test in order to assess differences in the distribution of
VSX1 polymorphism between cases and controls. The al-
lelic p-value and odds ratio was determined for each of
the identified VSX1 variants.
Results & discussion
A total of 117 sporadic KTCN patients were analyzed
for coding and flanking intronic regions of VSX1
through bidirectional DNA sequencing analysis. In the
VSX1 gene screening, no pathogenic mutations were
identified whereas, four reported single nucleotide
polymorphisms c.546A>G (rs12480307), c.627+23G>A
(rs6138482), c.627+84T>A (rs56157240) and c.504-
24C>T (IVS3-24C) could be observed (Table 1). Further,
these four SNPs were investigated in 108 ethnic-matched
healthy controls, and their genotype and allele frequency
was compared between cases and control. The com-
parative statistical analysis of allele frequency of these
SNPs indicated similar distribution in both patient and
control groups (Table 2). The polymorphism c.546A>G
(rs12480307) was found in exon 3 encoding a synonym-
ous alanine substitution at 182 amino acid position,
which is highly conserved throughout many species. ThisTable 1 VSX1 sequence variants observed in the study








rs12480307 NM_014588 c.546A>G NP_055403 p.A182A
rs6138482 NM_014588 c.627+23G>A NP_055403 . . .
rs56157240 NM_014588 c.627+84T>A NP_055403 . . .
(IVS3-24C) NM_014588 c.504-24C>T NP_055403 . . .variation was seen in 43 cases (36 heterozygous and 7
homozygous) and 32 controls (28 heterozygous and 4
homozygous). The statistical analysis showed no significant
difference of allelic distribution (p value 0.205) among
cases and controls. The polymorphic variant c.627+23G>A
(rs6138482) was found in 29 cases (26 heterozygous and 3
homozygous) and 41 controls (40 heterozygous and 1
homozygous). The statistical analysis showed the allelic p
value 0.099, which was insignificant. The polymorphic vari-
ant c.627+84T>A (rs56157240) was found in 58 cases (49
heterozygous and 9 homozygous) and 50 controls (43 het-
erozygous and 7 homozygous) with no significant differ-
ence of allelic distribution between case and control
groups (p value 0.595). Another variant IVS3-24C>T
(c.504-24C>T) was identified in 7 cases (7 heterozygous
and 0 homozygous) and 7 controls (7 heterozygous and 0
homozygous) signifying its equal distribution (allelic p-
value 0.879) between cases and controls. This change was
recently reported by Mukesh Tanwar et al., [25] as a novel
VSX1 variant, and registered in GenBank [Accession num-
ber : GU471016].
Conclusions
In our study, we have assessed the role of VSX1 by se-
quence analysis of its five exons in 117 sporadic KTCN
patients. Our screening showed the absence of patho-
genic variations whereas, four previously reported SNPs
were observed. Since no pathogenic changes were
detected, we compared the genotype and allele frequency
of each of the identified polymorphisms between the dis-
ease cohort and healthy controls to access their possible
disease involvement. However, allele frequencies of these
identified SNPs were found in similar frequency between
cases and controls confirming their non-pathogenicity.
Other VSX1 gene variations such as p.D144E, p.L17P,
p.N151S p.G160D, p.P247R, p.L159M, p.G160V, p.Q175H,
p.R166W and p.H244R, reported in different previous
VSX1 studies were not identified in our analysis
[18-22,24,29]. There are few earlier studies, which have
indicated the association of non pathogenic VSX1
variations. Stabuc-Silih et al., [25] found an absence of
VSX1 pathogenic mutations but observed an associ-
ation of c.650G>A polymorphism (p=0.043) in unre-
lated Slovenian patients diagnosed with the hereditary
form of KTCN. Mok et al., [20] found a significant
association of one VSX1 intragenic polymorphism
‘IVS1-11’ in unrelated Korean keratoconus patients
(p=0.001). Mutational screening of 66 unrelated pa-
tients with keratoconus (27 familial cases; 39 sporadic
cases) from the European population, showed a minor
role of VSX1 in the pathogenesis of keratoconus [22].
However, several other studies have shown the absence
of pathogenic variations or lack of association of VSX1
variants with KTCN. Tang YG et al., [29] ruled out
Table 2 Frequencies of VSX1 gene variants in sporadic KTCN cases and healthy controls
VSX1 gene variations Case Control Allelic
p value
OR (95% CI)
n=117 % n=108 %
(rs12480307) c.546A>G Genotype AA 74 63.2 76 70.4
GA 36 30.8 28 25.9
GG 7 6.0 4 3.7
Allele A 184 78.6 180 83.4 0.205 0.74 (0.44-1.21)
G 50 21.4 36 16.6
(rs6138482) c.627+23G>A Genotype GG 88 75.2 67 62.0
GA 26 22.2 40 37.0
AA 3 2.6 1 0.9
Allele G 202 86.3 174 80.6 0.099 0.66 (0.38-1.12)
A 32 13.7 42 19.4
(rs56157240) c.627+84T>A Genotype TT 59 50.4 58 53.7
TA 49 41.9 43 39.8
AA 9 7.7 7 6.5
Allele T 167 71.4 159 73.6 0.595 1.12 (0.72-1.73)
A 67 28.6 57 26.4
IVS3-24C>T c.504-24C>T Genotype CC 110 94.0 101 93.5
CT 7 6..0 7 6.5
TT 0 0 0 0
Allele C 227 97 209 96.7 0.879 1.09 (0.32-3.69)
T 7 3 7 3.3
OR-odds ratio, CI- confidence interval, p-value less than 0.05 was considered as significant.
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a case–control study of 77 white KTCN patients. Liskova
et al., [28], in a study of 85 familial keratoconus pedigrees
from different ethnic origins, found a lack of pathogenic
variations in VSX1 and disqualified the previously
reported c.432C>G (p.D144E) change to be pathogenic.
Aldave et al., [27] found the absence of mutation in
100 unrelated KTCN subjects and concluded that VSX1
mutations are not associated with keratoconus. Overall,
our study also rules out the possible involvement of
VSX1 gene in sporadic, South Indian KTCN patients.
However, few previous evidence of VSX1 pathogenic
variations and their association with disease, suggest
that it is more likely to be involved in a smaller subset
of the KTCN population. The role of VSX1 variations
in a minority of keratoconus patients may be influenced
by its possible variable penetrance or pleiotropic effect
in corneal tissue.
Our study supports the previous evidence of lack of
pathogenic variations in VSX1, and corroborates the in-
volvement of new genes, loci or any other genetic or
environmental factors. Linkage analysis and association
study are the two main approaches used to identify
novel genes. Genome wide association study (GWAS) is
a more useful approach as it is wide-ranging, unbiasedand can be applied even in the absence of convincing
indication regarding the function or location of the
causal genes. The other genetic factors are needed to
be investigated for KTCN pathogenesis. Abu-Amero
et al., [32], analyzed VSX1 chromosomal copy number
variations (deletions/duplications) in a group of spor-
adic patients, who were excluded for VSX1 mutations,
and verified that such possible genetic changes are also
not involved in keratoconus. Recent studies find that
keratoconus corneas have signs of oxidative stress and
high level of mitochondrial DNA damage [33]. More re-
cent findings suggest that micro-RNA can be involved
in the pathogenesis of keratoconus [34]. Therefore,
mitochondrial genes and micro-RNA are the prospect-
ive emerging areas to explore in the context of other
genetic factors related to keratoconus. Proteomic pro-
files in the KTCN corneas and tear have shown differ-
ential expression of several proteins, which may have
possible role in the etiology of keratoconus [35-37].
Hence, genetic and proteomic approaches together can
provide more useful information regarding disease eti-
ology. For the genetic basis of keratoconus, other gen-
etic factors, new chromosomal loci and genes are the
subject of investigation to accomplish the better under-
standing of the pathogenesis of disease.
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